Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Jasmina Djordjevic
 -- 1519 2023-10-09 11:51:37 |
2 The section 3 has been added, introduction has been improved.
Halil Bulut
 + 225 word(s) 1744 2023-10-09 20:16:24 | |
3 only format change
Alfred Zheng
Meta information modification 1744 2023-10-12 10:30:29 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Bulut, H.I.; Arjomandi Rad, A.; Syrengela, A.; Ttofi, I.; Djordjevic, J.; Kaur, R.; Keiralla, A.; Krasopoulos, G. Aetiology of Bicuspid Aortic Valve. Encyclopedia. Available online: https://encyclopedia.pub/entry/49970 (accessed on 13 May 2024).
Bulut HI, Arjomandi Rad A, Syrengela A, Ttofi I, Djordjevic J, Kaur R, et al. Aetiology of Bicuspid Aortic Valve. Encyclopedia. Available at: https://encyclopedia.pub/entry/49970. Accessed May 13, 2024.
Bulut, Halil Ibrahim, Arian Arjomandi Rad, Angeliki-Aikaterini Syrengela, Iakovos Ttofi, Jasmina Djordjevic, Ramanjit Kaur, Amar Keiralla, George Krasopoulos. "Aetiology of Bicuspid Aortic Valve" Encyclopedia, https://encyclopedia.pub/entry/49970 (accessed May 13, 2024).
Bulut, H.I., Arjomandi Rad, A., Syrengela, A., Ttofi, I., Djordjevic, J., Kaur, R., Keiralla, A., & Krasopoulos, G. (2023, October 09). Aetiology of Bicuspid Aortic Valve. In Encyclopedia. https://encyclopedia.pub/entry/49970
Bulut, Halil Ibrahim, et al. "Aetiology of Bicuspid Aortic Valve." Encyclopedia. Web. 09 October, 2023.
Aetiology of Bicuspid Aortic Valve
Edit
This entry is adapted from the peer-reviewed paper 10.3390/jcdd10090398

BAV (Bicuspid Aortic Valve) stands as the most prevalent congenital heart condition closely linked to critical and potentially life-threatening cardiac and aortic ailments, including aortic stenosis, aortic insufficiency, aortic aneurysms, and aortic dissection. It is believed that both genetic and epigenetic factors influence the etiology of BAV. Gaining insight into this underlying causative framework is paramount in guiding treatment strategies for BAV and its associated pathologies.

BAV bicuspid aortic valve

1. Introduction

Bicuspid aortic valve (BAV) is a congenital heart disease characterized by the presence of two commissures, rather than the usual three[1]. BIt affects approximately 1-2% of the general population, making it the most common congenital heart disease [2]. The exact cause of BAV remains unclear, but it has been associated with various genetic syndromes and disorders, including Shone complex, Kabuki syndrome, and Marfan syndrome, as well as genetic variations and mutations [3][4].  Initially, BAV was thought to be a connective tissue disease like Marfan syndrome. However, subsequent observational and clinical studies have shown that BAV does not affect connective tissue to the same extent[5][6]. Nonetheless, BAV patients still face a higher risk of aortic complications compared to those with a tricuspid aortic valve. A significant proportion of BAV patients requiring aortic valve replacement (AVR) or repair surgery also require concurrent aortic surgery due to BAV-associated aeropathy[7][8]. Despite the high rates of aortic surgery in BAV patients, ongoing debate surrounds the threshold for concurrent aortic surgery based on aortic dimensions[9][10].hese thresholds now vary, taking into account the genetic profiles of the patients and the characteristics of the aortic wall.

2. Aetiology of Bicuspid Aortic Valve

Despite being the most prevalent congenital heart disease, the aetiology and pathogenesis of bicuspid aortic valve morphology remain partially understood. However, the prevailing consensus within the literature suggests that this morphological condition is underpinned by a robust and intricate genetic basis.

2.1. Bicuspid Aortic Valve and Genetic Background

The occurrence of BAV within families is notably 5 to 15 times more prevalent than in the general population, pointing towards a likely genetic basis for this correlation [11]. Importantly, the male-to-female ratio in cases of BAV is evenly distributed at 1:1, which contrasts with the gender patterns observed in numerous acquired heart conditions [11]. In a study by Boureau et al., in which they focused on patients with calcific aortic valve disease, it was revealed that isolated cases of calcific aortic valve disease were more likely to show tricuspid morphology. Conversely, cases of calcific aortic valve disease presenting in a familial pattern showed predominantly bicuspid valve morphology [12]. Emphasizing the criticality of the issue, Tessler et al. emphasized the importance of performing echocardiographic evaluation in first-degree relatives of individuals diagnosed with BAV [13].
Examining the congenital syndromes associated with BAV holds substantial significance in unravelling the formation and potential pathogenesis of BAV itself. As depicted in Table 1, the incidence of BAV within congenital heart diseases provides insightful data. For instance, a notable correlation exists between BAV and the Shone complex, a condition characterized by a defect in the myocardial structural protein (MYH6). Remarkably, approximately 9 out of 10 patients with the Shone complex exhibit BAV, which is a severe form of left heart structural abnormality. Additionally, BAV is present in about one-third of patients with ventricular septal defect (VSD), suggesting a possible link to neural crest cell migration processes. Particularly striking is the elevated prevalence of BAV in conditions such as Turner and Kabuki syndromes. These syndromes, known to disrupt valvular microenvironmental homeostasis due to genetic impairments, exhibit a prevalence of BAV exceeding 10 times that of the general population (21% vs. 2%). This recurrent presence of BAV in such syndromes underscores its intricate association with conditions involving compromised neural crest migration and gene abnormalities that potentially disrupt the valvular microenvironment [14][15][16][17][18][19][20][21][22][23][24][25][26].
Table 1. Bicuspid aortic valve prevalence in congenital heart and vascular diseases.
Syndrome Name BAV Prevalence * Reference
Shone complex 88% [14]
Ventricular septal defect (VSD) 30% [15]
Turner syndrome 21% [16]
Kabuki syndrome 21% [17]
Adams–Oliver syndrome 13.3% [18]
Hypoplastic left heart syndrome 11% [19]
Tetralogy of Fallot 6.5% [20]
Loesy–Dietz syndrome 6% [21]
Marfan syndrome 4.7% [22]
ACTA2 mutated patients 3% [15]
Velocardiofacial syndrome 10% [23]
* Bicuspid aortic valve prevalence in general is 0.5–2%.
Table 2 presents a comprehensive overview of the genes associated with bicuspid aortic valve disease, believed to contribute to the development of this specific valve morphology [27][28][29][30][31][32][33][34][35][36][37][38][39][40]. Upon closer examination of these genes and the pathways they participate in, alongside congenital heart syndromes commonly featuring BAV, the genetic foundation of BAV can be succinctly summarized as follows:
Table 2. Genes Associated with Bicuspid Aortic Valve.
Gene Name Variations Reference
ROBO4 exon 13(c.2056+1G>T), R64C, A95T, T232M
H411G, R568X, R64C, V247A, Y280S, G534Efs49,
N622H, A749L, N510V, Ser327Pro		 [27][34][36]
GATA GATA4(rs6601627, S337G)
GATA5(L233P, S19Y, Y143H, G166S, Y16D, T252P,
Q3R, c.830C>T/p. P277L, p. (Gln3Arg))
GATA6(E38X)		 [28][29][30][31][32][33][34][35][36]
NOTCH1 9q34-35, A1343V, P1390T, H1505del
R1108x, T596M, P1797H, R1350L,
P1377S,.873C>G/p. Tyr291		 [34][37]
FBN1 - [34]
SMAD6 C484F, P415L, K242NfsX300, Gly166VfsX23,
G26_S27del, Y279X, Y288X, V239M, P257L,
G271W, G406C, H408Q, R443H		 [34]
TGFBR2 V387M [30]
KCNJ2 R67W [40]
NKX2-5 K192X [34]
NRF2F C96X [34]
MCTP2 L847F, T545M [34]
AXIN1/2 R841Q, A684V [34]
NFATC1 P77L, V210M [34]
TBX5 S372L; V263M [34]
KFL13 Glu144-mutant [38]
CELSR1 - [39]
  • Function and Dysfunction of Cardiogenesis-Polarization Genes: Notably, genes integral to cardiogenesis, such as GATA and NKX2-5, play a pivotal role. These genes are central to the establishment and proper functioning of the heart.
  • Dysregulation of Genes Associated with Neural Crest Cell Migration: Genes like ROBO4, implicated in the regulation of neural crest cell migration, also feature in the genetic context of BAV. Dysfunction here might contribute to anomalies in cardiac development.
  • Defects and Disorders in Genes Governing Valve Microenvironment Maintenance: The integrity of the valve microenvironment relies on genes like TGFB2 and TBX. Irregularities in these genes can potentially lead to disruptions in the microenvironment, affecting valve development.
  • Gene Aberrations in Structural Aspects of Connective Tissues: Structural issues concerning connective tissues are influenced by gene disorders, including FBN1 deficiency. These genetic irregularities can give rise to problems in the structural integrity of tissues that constitute the cardiovascular system.
In essence, the genetic underpinnings of BAV encompass a complex interplay of various genetic factors and pathways. The intricate dance between genes related to cardiogenesis, neural crest cell migration, valve microenvironment maintenance, and connective tissue structure collectively shapes the development of BAV. This holistic understanding underscores the multifaceted nature of the genetic basis behind BAV’s manifestation.

2.2. Genetical Background of Bicuspid Aortic Valve and Aorta

Genetic factors play an important role in the formation of BAV morphology as well as in the development of related aortic problems. Specifically, when genes responsible for structurally regulating connective tissue encounter disruptions or when genes essential for maintaining the valve microenvironment experience dysregulation, the result is weakening of the aortic structure [6][7][8][9][15]. While it is crucial to acknowledge that genetic anomalies are not the sole origin of aortic pathologies, they are acknowledged as a constituent aspect of the overall pathogenic process, shedding light on the complex interplay between genetic factors and the emergence of aortic complications.

2.3. Hemodynamic Features of Bicuspid Aortic Valve

Epigenetic factors have been suggested to contribute to aortic complications in patients with BAV. The non-linear blood flow across the BAV and its direction, which is influenced by the specific subtype category of BAV pathology, play a significant role [41]. The turbulent jet flow over the BAV increases wall shear stress on the valve and the associated areas of the ascending root and ascending aorta. Consequently, high wall shear stress leads to various epigenetic changes in smooth muscle cells, endothelial cells, and valvular interstitial cells. Increased wall shear stress triggers the expression of proinflammatory cytokines and proteins, potentially resulting in the thickening of valve cusps and degeneration of the aortic media. Studies by Rashad et al. have demonstrated the upregulation of pro-atherogenic factors (such as ICAM1 and E-selectin), pro-angiogenic factors (such as KFL2), and pro-vascular fibrotic factors (such as NOS) in response to high wall shear stress, as observed in patients with BAV [42].
The hemodynamic changes associated with BAV also contribute to the different types of aortic dilatation and aneurysm formation observed in BAV aortopathy. Arch dilatation is more common in patients with R-N cusp fusion, with jet streams directed toward the arch, whereas ascending aortic aneurysms are more prevalent in patients with L-R fusions, with jet streams directed toward the ascending aorta [43]. In a study by Charitos et al. involving 361 BAV patients and 448 patients undergoing tricuspid AVR, no difference in aortic dilatation or an increase in the size of the middle root was observed between BAV and tricuspid AVR patients after surgery. The authors concluded that aortic dilatation in BAV is primarily due to valve hemodynamics rather than genetic factors [44]. Fungi et al. reported a study involving 431 patients who underwent either isolated AVR, AVR with ascending aorta replacement, or aortic root replacement between 1993 and 2019. Their findings indicated that concomitant aortic surgery during aortic valve surgery for BAV does not impact survival in patients with BAV whose ascending aorta diameter ranges from 40 mm to 45 mm [45].

3. Aetiology and Significant Thresholds for Intervention

Epigenetic and genetic factors that contribute to the etiology of BAV and its associated conditions hold paramount importance in treatment planning for the disease. While the standard aortic intervention threshold is 55 mm, experienced centers may lower it to 50 mm for BAV cases. Furthermore, in patients undergoing AVR, this threshold may decrease to 45 mm. Additionally, factors like epigenetic influences and accompanying conditions such as aortic regurgitation and wall stress play a significant role in influencing this threshold. Moreover, specific genetic disorders implicated in bicuspid valve etiology have distinct cut-off values.

In clinical practice, aortic aneurysms are classified based on their diameter, which serves as a crucial indicator for determining the appropriate intervention. As the aortic diameter reaches the 40-45 mm range, genetic mutations in genes like TGFBR1, TGFBR2, and SMAD3 become particularly relevant in assessing the risk of aneurysm progression and rupture [46]. Expanding further to 45-50 mm, additional genetic factors including ACTA2, COL3A1, and FBN1 come into focus, significantly influencing the clinical course and management of aortic aneurysms [46]. This nuanced understanding of genetic factors at varying diameter thresholds empowers clinicians to make more precise and tailored decisions regarding the treatment and surveillance of patients with aortic aneurysms.

Threshold for Aortic Intervention Genes  Reference
40-45 mm

TGFBR1/2

SMAD3 

 [46]
45-50 mm

ACTA2 

COL3A1

FBN1

 [46]

References

  1. Detaint, D.; Michelena, H.I.; Nkomo, V.T.; Vahanian, A.; Jondeau, G.; Sarano, M.E. Aortic dilatation patterns and rates in adults with bicuspid aortic valves: A comparative study with Marfan syndrome and degenerative aortopathy. Heart 2014, 100, 126–134.
  2. Aluru, J.S.; Barsouk, A.; Saginala, K.; Rawla, P.; Barsouk, A. Valvular Heart Disease Epidemiology. Med. Sci. 2022, 10, 32.
  3. Bolar, N.; Verstraeten, A.; Van Laer, L.; Loeys, B. Molecular insights into bicuspid aortic valve development and the associated aortopathy. AIMS Mol. Sci. 2017, 4, 478–508.
  4. Kodolitsch, Y.V.; Kaemmerer, H. Bicuspid aortic valve. In Aortopathy; Springer: Tokyo, Japan, 2017; pp. 229–256.
  5. Michelena, H.I.; Prakash, S.K.; Della Corte, A.; Bissell, M.M.; Anavekar, N.; Mathieu, P.; Bosse, Y.; Limongelli, G.; Bossone, E.; Benson, D.W.; et al. Bicuspid aortic valve: Identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). Circulation 2014, 129, 2691–2704.
  6. Itagaki, S.; Chikwe, J.P.; Chiang, Y.P.; Egorova, N.N.; Adams, D.H. Long-Term Risk for Aortic Complications After Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Versus Marfan Syndrome. J. Am. Coll. Cardiol. 2015, 65, 2363–2369.
  7. Junco-Vicente, A.; Del Río-García, Á.; Martín, M.; Rodríguez, I. Update in Biomolecular and Genetic Bases of Bicuspid Aortopathy. Int. J. Mol. Sci. 2021, 22, 5694.
  8. Girdauskas, E.; Disha, K.; Borger, M.A.; Kuntze, T. Risk of proximal aortic dissection in patients with bicuspid aortic valve: How to address this controversy? Interact. Cardiovasc. Thorac. Surg. 2014, 18, 355–359.
  9. Kallenbach, K.; Sundt, T.M.; Marwick, T.H. Aortic surgery for ascending aortic aneurysms under 5.0 cm in diameter in the presence of bicuspid aortic valve. JACC Cardiovasc. Imaging 2013, 6, 1321–1326.
  10. Martín, M.; Lorca, R.; Rozado, J.; Alvarez-Cabo, R.; Calvo, J.; Pascual, I.; Cigarran, H.; Rodriguez, I.; Morís, C. Bicuspid aortic valve syndrome: A multidisciplinary approach for a complex entity. J. Thorac. Dis. 2017, 9 (Suppl. S6), S454.
  11. Bravo-Jaimes, K.; Prakash, S.K. Genetics in bicuspid aortic valve disease: Where are we? Prog. Cardiovasc. Dis. 2020, 63, 398–406.
  12. Boureau, A.S.; Karakachoff, M.; Le Scouarnec, S.; Capoulade, R.; Cueff, C.; de Decker, L.; Senage, T.; Verhoye, J.-P.; Baufreton, C.; Roussel, J.-C.; et al. Heritability of aortic valve stenosis and bicuspid enrichment in families with aortic valve stenosis. Int. J. Cardiol. 2022, 359, 91–98.
  13. Tessler, I.; Leshno, M.; Shmueli, A.; Shpitzen, S.; Durst, R.; Gilon, D. Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve. Eur. Heart J. Qual. Care Clin. Outcomes 2021, 7, 447–457.
  14. Escárcega, R.O.; Michelena, H.I.; Bove, A.A. Bicuspid aortic valve: A neglected feature of Shone’s complex? Pediatr. Cardiol. 2014, 35, 186–187.
  15. Borger, M.A.; Fedak, P.W.; Stephens, E.H.; Gleason, T.G.; Girdauskas, E.; Ikonomidis, J.S.; Khoynezhad, A.; Siu, S.C.; Verma, S.; Hope, M.D.; et al. The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve–related aortopathy: Full online-only version. J. Thorac. Cardiovasc. Surg. 2018, 156, e41–e74.
  16. Donadille, B.; Rousseau, A.; Zenaty, D.; Cabrol, S.; Courtillot, C.; Samara-Boustani, D.; Salenave, S.; Monnier-Cholley, L.; Meuleman, C.; Jondeau, G.; et al. Cardiovascular findings and management in Turner syndrome: Insights from a French cohort. Eur. J. Endocrinol. 2012, 167, 517–522.
  17. Digilio, M.C.; Gnazzo, M.; Lepri, F.; Dentici, M.L.; Pisaneschi, E.; Baban, A.; Passarelli, C.; Capolino, R.; Angioni, A.; Novelli, A.; et al. Congenital heart defects in molecularly proven Kabuki syndrome patients. Am. J. Med. Genet. Part A 2017, 173, 2912–2922.
  18. Zapata, H.H.; Sletten, L.J.; Pierpont, M.E.M. Congenital Cardiac Malformations in Adams-Oliver Syndrome. Clin. Genet. 2008, 47, 80–84.
  19. Hinton, R.B.; Martin, L.J.; Tabangin, M.E.; Mazwi, M.L.; Cripe, L.H.; Benson, D.W. Hypoplastic left heart syndrome is heritable. J. Am. Coll. Cardiol. 2007, 50, 1590–1595.
  20. Egbe, A.C.; Crestanello, J.; Miranda, W.R.; Connolly, H.M. Thoracic aortic dissection in tetralogy of Fallot: A review of the National Inpatient Sample Database. J. Am. Heart Assoc. 2019, 8, e011943.
  21. Patel, N.D.; Crawford, T.; Magruder, J.T.; Alejo, D.E.; Hibino, N.; Black, J.; Dietz, H.C.; Vricella, L.A.; Cameron, D.E. Cardiovascular operations for Loeys-Dietz syndrome: Intermediate-term results. J. Thorac. Cardiovasc. Surg. 2017, 153, 406–412.
  22. Giusti, B.; Sticchi, E.; De Cario, R.; Magi, A.; Nistri, S.; Pepe, G. Genetic bases of bicuspid aortic valve: The contribution of traditional and high-throughput sequencing approaches on research and diagnosis. Front. Physiol. 2017, 8, 612.
  23. John, A.S.; McDonald-McGinn, D.M.; Zackai, E.H.; Goldmuntz, E. Aortic root dilation in patients with 22q11.2 deletion syndrome. Am. J. Med. Genet. A 2009, 149A, 939–942.
  24. Russell, M.W.; Chung, W.K.; Kaltman, J.R.; Miller, T.A. Advances in the understanding of the genetic determinants of congenital heart disease and their impact on clinical outcomes. J. Am. Heart Assoc. 2018, 7, e006906.
  25. Williams, K.; Carson, J.; Lo, C. Genetics of Congenital Heart Disease. Biomolecules 2019, 9, 879.
  26. Choudhury, T.Z.; Garg, V. Molecular Genetic Mechanisms of Congenital Heart Disease. Curr. Opin. Genet. Dev. 2022, 75, 101949.
  27. Gould, R.A.; Aziz, H.; Woods, C.E.; Seman-Senderos, M.A.; Sparks, E.; Preuss, C.; Wünnemann, F.; Bedja, D.; Moats, C.R.; McClymont, S.A.; et al. ROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm. Nat. Genet. 2019, 51, 42–50.
  28. Bonachea, E.M.; Chang, S.W.; Zender, G.; LaHaye, S.; Fitzgerald-Butt, S.; McBride, K.L.; Garg, V. Rare GATA5 sequence variants identified in individuals with bicuspid aortic valve. Pediatr. Res. 2014, 76, 211–216.
  29. Padang, R.; Bagnall, R.D.; Richmond, D.R.; Bannon, P.G.; Semsarian, C. Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease. J. Mol. Cell. Cardiol. 2012, 53, 277–281.
  30. Shi, L.M.; Tao, J.W.; Qiu, X.B.; Wang, J.; Yuan, F.; Xu, L.; Liu, H.; Li, R.G.; Xu, Y.J.; Wang, Q.; et al. GATA5 loss-of-function mutations associated with congenital bicuspid aortic valve. Int. J. Mol. Med. 2014, 33, 1219–1226.
  31. Xu, Y.J.; Di, R.M.; Qiao, Q.; Li, X.M.; Huang, R.T.; Xue, S.; Liu, X.Y.; Wang, J.; Yang, Y.Q. GATA6 loss-of-function mutation contributes to congenital bicuspid aortic valve. Gene 2018, 663, 115–120.
  32. Li, R.G.; Xu, Y.J.; Wang, J.; Liu, X.Y.; Yuan, F.; Huang, R.T.; Xue, S.; Li, L.; Liu, H.; Li, Y.J.; et al. Gata4 loss-of-function mutation and the congenitally bicuspid aortic valve. Am J Cardiol. 2018, 121, 469–474.
  33. Tessler, I.; Albuisson, J.; Goudot, G.; Carmi, S.; Shpitzen, S.; Messas, E.; Gilon, D.; Durst, R. Bicuspid aortic valve: Genetic and clinical insights. Aorta 2021, 9, 139–146.
  34. Parker, L.E.; Landstrom, A.P. Genetic Etiology of Left-Sided Obstructive Heart Lesions: A Story in Development. J. Am. Heart Assoc. 2021, 10, e019006.
  35. Jin, J.Y.; Wu, L.P.; Dong, Y.; Pi, H.C.; Wu, H.F.; Xiang, R. Identification of a novel GATA binding protein 5 variant (c. 830C > T/p. P277L) damaging the nuclear translocation and causing tetralogy of Fallot. QJM Int. J. Med. 2022, 115, 256–258.
  36. Jaouadi, H.; Gérard, H.; Théron, A.; Collod-Béroud, G.; Collart, F.; Avierinos, J.F.; Zaffran, S. Identification of non-synonymous variations in ROBO1 and GATA5 genes in a family with bicuspid aortic valve disease. J. Hum. Genet. 2022, 67, 515–518.
  37. Debiec, R.M.; Hamby, S.E.; Jones, P.D.; Safwan, K.; Sosin, M.; Hetherington, S.L.; Sprigings, D.; Sharman, D.; Lee, K.; Salahshouri, P.; et al. Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions. Heart 2022, 108, 1114–1120.
  38. Abhinav, P.; Zhang, G.F.; Zhao, C.M.; Xu, Y.J.; Wang, J.; Yang, Y.Q. A novel KLF13 mutation underlying congenital patent ductus arteriosus and ventricular septal defect, as well as bicuspid aortic valve. Exp. Ther. Med. 2022, 23, 1–9.
  39. Theis, J.L.; Niaz, T.; Sundsbak, R.S.; Fogarty, Z.C.; Bamlet, W.R.; Hagler, D.J.; Olson, T.M. CELSR1 risk alleles in familial bicuspid aortic valve and hypoplastic left heart syndrome. Circ. Genom. Precis. Med. 2022, 15, e0035.
  40. Bonachea, E.M.; Zender, G.; White, P.; Corsmeier, D.; Newsom, D.; Fitzgerald-Butt, S.; Garg, V.; McBride, K.L. Use of a Target-ed, Combinatorial next-Generation Sequencing Approach for the Study of Bicuspid Aortic Valve. BMC Med. Genom. 2014, 7.
  41. Rashad, S.; Han, X.; Saqr, K.; Tupin, S.; Ohta, M.; Niizuma, K.; Tominaga, T. Epigenetic response of endothelial cells to different wall shear stress magnitudes: A report of new mechano-miRNAs. J. Cell. Physiol. 2020, 235, 7827–7839.
  42. Cao, K.; Sucosky, P. Predictions of Wall-shear Stress on the Bicuspid Aortic Valves Using Three-dimensional Fluid-structure Interaction Models. Circulation 2014, 130 (Suppl. S2).
  43. Saikrishnan, N.; Yap, C.H.; Milligan, N.C.; Vasilyev, N.V.; Yoganathan, A.P. In vitro characterization of bicuspid aortic valve hemodynamics using particle image velocimetry. Ann. Biomed. Eng. 2012, 40, 1760–1775.
  44. Charitos, E.I.; Stierle, U.; Petersen, M.; Mohamed, S.A.; Hanke, T.; Schmidtke, C.; Klotz, S.; Sievers, H.H. The fate of the bicuspid valve aortopathy after aortic valve replacement. Eur. J. Cardio-Thorac. Surg. 2014, 45, e128–e135.
  45. Longi, F.; Orelaru, F.; Clemence, J., Jr.; Naeem, A.; Wu, X.; Yang, B. Outcomes of bicuspid aortic valve thoracic aorta (4.0–4.5 cm) after aortic valve replacement. Ann. Thorac. Surg. 2022, 113, 1521–1528.
  46. Syrengela, A.-A.; Shahjahan, S.; Bulut, H.I.; Ttofi, I.; Djordjevic, J.; Krasopoulos, G. How Important are Genetics in the Management of Thoracic Aortic Aneurysms and Acute Aortic Syndromes? What do we Know Today?. J. Surg. 2023, 8, epub ahead of print.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Cardiac & Cardiovascular Systems
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Halil Ibrahim Bulut
,
Arian Arjomandi Rad
,
Angeliki-Aikaterini Syrengela
,
Iakovos Ttofi
,
Jasmina Djordjevic
,
Ramanjit Kaur
,
Amar Keiralla
,
George Krasopoulos
View Times: 384
Revisions: 3 times (View History)
Update Date: 12 Oct 2023
Table of Contents
    1000/1000
    Hot Most Recent
    Feedback